CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
The influence of steroid metabolism on CYP17A1 inhibitor activity | Nature Reviews Urology
Biased cytochrome P450-mediated metabolism via small-molecule ligands binding P450 oxidoreductase | Nature Communications
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
Frontiers | Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer | Nature Reviews Urology
Molecules | Free Full-Text | Enzyme Activity of Natural Products on Cytochrome P450
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
Drug discovery in advanced prostate cancer: translating biology into therapy | Nature Reviews Drug Discovery
Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 | Nature
An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase | Communications Biology
CYP17 inhibition as a hormonal strategy for prostate cancer | Nature Reviews Urology
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors | Scientific Reports
ARe we there yet? Understanding androgen receptor signaling in breast cancer | npj Breast Cancer
Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models | Scientific Reports
Resistance to second-generation androgen receptor antagonists in prostate cancer | Nature Reviews Urology
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer | Nature Reviews Cancer
Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases | Chemical Research in Toxicology
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
Mechanisms of resistance to CYP17 inhibitors. Androgen receptor (AR)... | Download Scientific Diagram
CYP17 inhibitors in prostate cancer: latest evidence and clinical potential - Anitha B. Alex, Sumanta K. Pal, Neeraj Agarwal, 2016
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors | Scientific Reports
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
CYP17 inhibitors for prostate cancer therapy - ScienceDirect
